je.st
news
Tag: nonalcoholic
Carlsberg sees non-alcoholic beer boom in Denmark, readies wheat variant
2016-01-19 15:20:00| Daily beverage news and comment - from just-drinks.com
Carlsberg has reported a leap in sales of its non-alcohol beer offering in its domestic market, and has lined up the release of a wheat variant.
Suntory loses patent dispute with Asahi over nonalcoholic beer
2015-10-29 13:32:04| Beverages - Topix.net
Suntory Holdings Ltd. lost a patent dispute with rival Asahi Breweries Ltd. on Thursday, with the Tokyo District Court rejecting its demand for a halt to production and sales of Asahi's nonalcoholic beer. Suntory had sought the suspension of Asahi's Dry Zero, which was relaunched in September 2013, alleging that it infringed a Suntory patent application filed in November 2012 and approved in October 2013.
Tags: patent
beer
dispute
loses
Ginebra sells non-alcoholic line to SMB
2015-05-05 03:17:30| Beverages - Topix.net
The hard liquor unit of diversified conglomerate San Miguel Corp. has completed the sale of its non-alcoholic beverage assets to sister company San Miguel Brewery Inc. for nearly P400 million. In a disclosure to the Philippine Stock Exchange yesterday, Ginebra San Miguel Inc. said a deed of sale has been executed with SMB for the sale of finished goods and other inventories including containers, packaging materials, goods in process and raw materials used by the former in its non-alcoholic beverage business for the purchase price of P214.97 million.
San Miguel Brewery eyeing non-alcoholic drinks
2015-01-06 13:50:17| Beverages - Topix.net
MANILA San Miguel Brewery Inc., a joint venture between San Miguel Corp. and Japan's Kirin Holdings Co. Ltd., is looking to expand its business to include non-alcoholic beverages.
Tags: san
miguel
drinks
brewery
La Jolla Pharmaceutical Announces Positive Pre-Clinical Data For Oral Galectin-3 Inhibitor In Nonalcoholic Steatohepatitis (NASH)
2014-07-30 09:57:01| drugdiscoveryonline Home Page
La Jolla Pharmaceutical Company (the “Company” or “La Jolla”), a leader in the development of therapeutics targeting significant unmet life-threatening diseases,recently announced positive pre-clinical data for LJPC-1010 in non-alcoholic steatohepatitis (NASH). LJPC-1010 is a derivative of GCS-100, a carbohydrate inhibitor of galectin-3, which has shown activity in chronic kidney disease in a Phase 2 trial
Tags: data
positive
oral
pharmaceutical
Sites : [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] next »